• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏代谢指数作为代谢功能障碍相关脂肪性肝病死亡率的预测指标。

Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease.

作者信息

Yang Yang, Zeng Cheng, Jin Zhiqiang, Huang Yi, Liu Huabao

机构信息

Chongqing Traditional Chinese Medicine Hospital, 400021, Chongqing, China.

Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, the Second Affiliated Hospital, Chongqing Medical University, 401336, Chongqing, China.

出版信息

BMC Gastroenterol. 2025 Jul 29;25(1):537. doi: 10.1186/s12876-025-04127-z.

DOI:10.1186/s12876-025-04127-z
PMID:40730948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12306038/
Abstract

BACKGROUND

Cardiometabolic Index (CMI) is positively correlated with liver fibrosis in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), but its association with mortality risk in MASLD patients remains unclear.

METHODS

This study utilized data from NHANES III and linked it with the mortality database up to December 31, 2019. Cox regression analysis was used to examine the relationship between CMI and mortality rates. Linear regression analysis was conducted to explore the correlation between CMI and the TyG index, and mediation analysis was performed to investigate the potential mechanisms underlying the association between CMI and mortality.

RESULTS

The study included 2,260 MASLD patients with a median age of 51 years and a median CMI of 2.5. In the fully adjusted Cox regression model, CMI was positively associated with all-cause mortality (per 1-SD increase, HR = 1.04, 95% CI = 1.00-1.08) and other-cause mortality rates (per 1-SD increase, HR = 1.25, 95% CI = 1.12–1.40), but not with cardiovascular or cancer-related mortality. Mediation analysis indicated that the TyG index mediated 16.6% of the association between CMI and all-cause mortality.

CONCLUSION

CMI in MASLD patients is associated with an increased risk of all-cause and other-cause mortality.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1186/s12876-025-04127-z.

摘要

背景

在代谢功能障碍相关脂肪性肝病(MASLD)患者中,心脏代谢指数(CMI)与肝纤维化呈正相关,但其与MASLD患者死亡风险的关联尚不清楚。

方法

本研究利用了美国国家健康与营养检查调查(NHANES)III的数据,并将其与截至2019年12月31日的死亡率数据库相链接。采用Cox回归分析来检验CMI与死亡率之间的关系。进行线性回归分析以探索CMI与TyG指数之间的相关性,并进行中介分析以研究CMI与死亡率之间关联的潜在机制。

结果

该研究纳入了2260例MASLD患者,中位年龄为51岁,中位CMI为2.5。在完全调整的Cox回归模型中,CMI与全因死亡率(每增加1个标准差,HR = 1.04,95%CI = 1.00 - 1.08)和其他原因死亡率(每增加1个标准差,HR = 1.25,95%CI = 1.12 - 1.40)呈正相关,但与心血管或癌症相关死亡率无关。中介分析表明,TyG指数介导了CMI与全因死亡率之间16.6%的关联。

结论

MASLD患者的CMI与全因和其他原因死亡风险增加相关。

补充信息

在线版本包含可在10.1186/s12876 - 025 - 04127 - z获取的补充材料。

相似文献

1
Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease.心脏代谢指数作为代谢功能障碍相关脂肪性肝病死亡率的预测指标。
BMC Gastroenterol. 2025 Jul 29;25(1):537. doi: 10.1186/s12876-025-04127-z.
2
Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2018.身体圆润度指数与代谢功能障碍相关脂肪性肝病成人全因死亡率和心血管死亡率风险之间的关联:1999 - 2018年美国国家健康与营养检查调查(NHANES)
Front Nutr. 2025 Jul 8;12:1604398. doi: 10.3389/fnut.2025.1604398. eCollection 2025.
3
Association between the dietary index for gut microbiota and all-cause/cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease.肠道微生物群饮食指数与代谢功能障碍相关脂肪性肝病患者全因/心血管死亡率之间的关联
Diabetol Metab Syndr. 2025 Jul 11;17(1):263. doi: 10.1186/s13098-025-01846-x.
4
Cardiometabolic dysfunction burden and mortality outcomes in metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病中的心脏代谢功能障碍负担及死亡率结局
PLoS One. 2025 Jul 3;20(7):e0327772. doi: 10.1371/journal.pone.0327772. eCollection 2025.
5
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.吉尔伯特综合征在代谢功能障碍相关脂肪性肝病(MASLD)患者中的意义:一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
6
Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease.肠道微生物群饮食指数和饮食炎症指数与代谢功能障碍相关脂肪性肝病及代谢性酒精性肝病的关联
Front Immunol. 2025 Jul 17;16:1593245. doi: 10.3389/fimmu.2025.1593245. eCollection 2025.
7
Association between metabolic score of visceral fat and all-cause mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a follow-up study based on NHANES III (1988-1994).代谢功能障碍相关脂肪性肝病患者内脏脂肪代谢评分与全因死亡率的关联:基于美国国家健康与营养检查调查III(1988 - 1994年)的随访研究
Diabetol Metab Syndr. 2025 Jul 30;17(1):302. doi: 10.1186/s13098-025-01864-9.
8
[Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic risk factor abnormalities with adverse pregnancy outcomes].代谢功能障碍相关脂肪性肝病及心血管代谢危险因素异常与不良妊娠结局的关联
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):487-495. doi: 10.19723/j.issn.1671-167X.2025.03.012.
9
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.心脏代谢指标与代谢功能障碍相关脂肪性肝病的发病及其向肝纤维化进展之间的关联:一项队列研究
Cardiovasc Diabetol. 2025 Apr 3;24(1):154. doi: 10.1186/s12933-025-02716-6.
10
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease.甘油三酯-血糖-腰围指数:代谢功能障碍相关脂肪性肝病的有力工具。
World J Hepatol. 2025 Jul 27;17(7):107668. doi: 10.4254/wjh.v17.i7.107668.

本文引用的文献

1
Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China.高血压患者的炎症指标与MAFLD患病率:来自中国的大规模横断面分析
J Inflamm Res. 2025 Feb 4;18:1623-1638. doi: 10.2147/JIR.S503648. eCollection 2025.
2
Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis.甘油三酯-葡萄糖指数变化轨迹及其与全因和心血管死亡率的关系:竞争风险分析。
Cardiovasc Diabetol. 2024 Oct 15;23(1):364. doi: 10.1186/s12933-024-02457-y.
3
Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH.
脂肪组织 ATF3 的缺失促进脂肪组织脂解和 MASH 的发展。
Commun Biol. 2024 Oct 10;7(1):1300. doi: 10.1038/s42003-024-06915-x.
4
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study.血浆醛固酮浓度与高血压患者 MAFLD 患病率的相关性:一项大规模横断面研究的启示。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1451383. doi: 10.3389/fendo.2024.1451383. eCollection 2024.
5
Association of the triglyceride-glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China.甘油三酯-葡萄糖指数与全因死亡率及特定病因死亡率的关联:一项基于中国350万成年人的队列研究。
Lancet Reg Health West Pac. 2024 Jul 6;49:101135. doi: 10.1016/j.lanwpc.2024.101135. eCollection 2024 Aug.
6
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.甘油三酯-葡萄糖相关指标与非酒精性脂肪性肝病或代谢相关脂肪性肝病患者死亡的相关性。
Cardiovasc Diabetol. 2024 Jul 4;23(1):232. doi: 10.1186/s12933-024-02343-7.
7
Strengths and Limitations of BMI in the Diagnosis of Obesity: What is the Path Forward?体质指数(BMI)在肥胖诊断中的优势和局限性:未来的发展方向是什么?
Curr Obes Rep. 2024 Sep;13(3):584-595. doi: 10.1007/s13679-024-00580-1. Epub 2024 Jul 3.
8
α-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1α/Nrf2 pathway.α-酮戊二酸通过激活 AMPK-pgc-1α/Nrf2 通路预防高脂血症诱导的脂肪肝线粒体功能障碍和氧化应激。
Redox Biol. 2024 Aug;74:103230. doi: 10.1016/j.redox.2024.103230. Epub 2024 Jun 13.
9
Association between the cardiometabolic index and NAFLD and fibrosis.中心血管代谢指数与非酒精性脂肪肝和纤维化的关系。
Sci Rep. 2024 Jun 8;14(1):13194. doi: 10.1038/s41598-024-64034-3.
10
The Lipid Accumulation Product Index (LAP) and the Cardiometabolic Index (CMI) Are Useful for Predicting the Presence and Severity of Metabolic Syndrome in Adult Patients with Obesity.脂质蓄积产物指数(LAP)和心脏代谢指数(CMI)有助于预测成年肥胖患者代谢综合征的存在及严重程度。
J Clin Med. 2024 May 11;13(10):2843. doi: 10.3390/jcm13102843.